Skip to content

Clinical trials

Phase 3 Immunoblastic Lymphadenopathy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoblastic Lymphadenopathy Phase: Phase 3 Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20012
20032
20051
20061
20072
20083
20091
20181
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Unknown status4
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jonsson Comprehensive Cancer Center3
Alliance for Clinical Trials in Oncology2
Memorial Sloan Kettering Cancer Center2
NCIC Clinical Trials Group2
Cancer Research Campaign Clinical Trials Centre1
Case Comprehensive Cancer Center1
Clatterbridge Centre for Oncology1
Corvus Pharmaceuticals, Inc.1
European Organisation for Research and Treatment of Cancer - EORTC1
Fudan University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoblastic Lymphadenopathy23
Lymphoma, Large-Cell, Anaplastic19
Lymphoma, Large B-Cell, Diffuse18
Burkitt Lymphoma17
Lymphoma, Follicular17
Lymphoma, Mantle-Cell17
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma17
Hodgkin Disease16
Leukemia, Lymphocytic, Chronic, B-Cell16
Lymphoma, B-Cell, Marginal Zone16

Trials

Showing 51 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.